Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension

被引:24
|
作者
Suresh, Karthik [1 ]
Servinsky, Laura [1 ]
Jiang, Haiyang [1 ]
Bigham, Zahna [1 ]
Zaldumbide, Joel [1 ]
Huetsch, John C. [1 ]
Kliment, Corrine [1 ]
Acoba, Michelle G. [2 ]
Kirsch, Brian J. [3 ]
Claypool, Steven M. [2 ]
Le, Anne [3 ]
Damarla, Mahendra [1 ]
Shimoda, Larissa A. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
关键词
calcium; endothelium; mitochondria; PAH; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; ROS GENERATION; CALCIUM INFLUX; COMPLEX-III; FISSION; TRPV4; DRP1; DYSFUNCTION; PHOSPHORYLATION;
D O I
10.1152/ajplung.00396.2018
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pulmonary arterial hypertension (PAH) is a morbid disease characterized by progressive right ventricle (RV) failure due to elevated pulmonary artery pressures (PAP). In PAH, histologically complex vaso-occlusive lesions in the pulmonary vasculature contribute to elevated PAP. However, the mechanisms underlying dysfunction of the microvascular endothelial cells (MVECs) that comprise a significant portion of these lesions are not well understood. We recently showed that MVECs isolated from the Sugen/hypoxia (SuHx) rat experimental model of PAH (SuHx-MVECs) exhibit increases in migration/proliferation, mitochondrial reactive oxygen species (ROS; mtROS) production, intracellular calcium levels ([Ca2+](i)), and mitochondrial fragmentation. Furthermore, quenching mtROS with the targeted antioxidant MitoQ attenuated basal [Ca2+](i), migration and proliferation; however, whether increased mtROS-induced [Ca2+](i) entry affected mitochondrial morphology was not clear. In this study, we sought to better understand the relationship between increased ROS, [Ca2+](i), and mitochondrial morphology in SuHx-MVECs. We measured changes in mitochondrial morphology at baseline and following inhibition of mtROS, with the targeted antioxidant MitoQ, or transient receptor potential vanilloid-4 (TRPV4) channels, which we previously showed were responsible for mtROS-induced increases in [Ca2+](i) in SuHx-MVECs. Quenching mtROS or inhibiting TRPV4 attenuated fragmentation in SuHx-MVECs. Conversely, inducing mtROS production in MVECs from normoxic rats (N-MVECs) increased fragmentation. Ca2+ entry induced by the TRPV4 agonist GSK1017920A was significantly increased in SuHx-MVECs and was attenuated with MitoQ treatment, indicating that mtROS contributes to increased TRPV4 activity in SuHx-MVECs. Basal and maximal respiration were depressed in SuHx-MVECs, and inhibiting mtROS, but not TRPV4, improved respiration in these cells. Collectively, our data show that, in SuHx-MVECs, mtROS production promotes TRPV4-mediated increases in [Ca2+](i), mitochondrial fission, and decreased mitochondrial respiration. These results suggest an important role for mtROS in driving MVEC dysfunction in PAH.
引用
收藏
页码:L639 / L652
页数:14
相关论文
共 50 条
  • [21] Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
    Alencar, Allan K. N.
    Pimentel-Coelho, Pedro M.
    Montes, Guilherme C.
    da Silva, Marina de M. C.
    Mendes, Luiza V. P.
    Montagnoli, Tadeu L.
    Silva, Ananssa M. S.
    Vasques, Juliana Ferreira
    Rosado-de-Castro, Paulo Henrique
    Gutfilen, Bianca
    Cunha, Valeria do M. N.
    Fraga, Aline G. M.
    Silva, Patricia M. R. E.
    Martins, Marco Aurelio
    Teixeira Ferreira, Tatiana Paula
    Mendes-Otero, Rosalia
    Trachez, Margarete M.
    Sudo, Roberto T.
    Zapata-Sudo, Gisele
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [22] A novel rat model of pulmonary hypertension induced by mono treatment with SU5416
    Yuqin Chen
    Meidan Kuang
    Shiyun Liu
    Chi Hou
    Xin Duan
    Kai Yang
    Wenjun He
    Jing Liao
    Qiuyu Zheng
    Guofa Zou
    Haixia Chen
    Han Yan
    Jiyuan Chen
    Yi Li
    Ying Zhou
    Xiaoyun Luo
    Qian Jiang
    Haiyang Tang
    Wenju Lu
    Jian Wang
    Hypertension Research, 2020, 43 : 754 - 764
  • [23] A novel rat model of pulmonary hypertension induced by mono treatment with SU5416
    Chen, Yuqin
    Kuang, Meidan
    Liu, Shiyun
    Hou, Chi
    Duan, Xin
    Yang, Kai
    He, Wenjun
    Liao, Jing
    Zheng, Qiuyu
    Zou, Guofa
    Chen, Haixia
    Yan, Han
    Chen, Jiyuan
    Li, Yi
    Zhou, Ying
    Luo, Xiaoyun
    Jiang, Qian
    Tang, Haiyang
    Lu, Wenju
    Wang, Jian
    HYPERTENSION RESEARCH, 2020, 43 (08) : 754 - 764
  • [24] Protracted Endothelial Cell Apoptosis Leads To Direct Microvascular Loss As A Major Mechanism Of Severe Pulmonary Arterial Hypertension In The Rat Su5416-Hypoxia Model
    Deng, Y.
    Chaudhary, K. R.
    Yang, A.
    Rowe, K. J.
    Stewart, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [25] Role of the Aryl Hydrocarbon Receptor in Su5416/Hypoxia-induced Pulmonary Hypertension: A New Mechanism for an "Old" Model
    Strielkov, Ievgen
    Weissmann, Norbert
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2018, 58 (03) : 279 - 281
  • [26] Detrimental Impact of Vasopressin V2 Receptor Antagonism in a SU5416/Hypoxia/Normoxia-Exposed Rat Model of Pulmonary Arterial Hypertension
    Goto, Itaru
    Dohi, Kaoru
    Ogihara, Yoshito
    Okamoto, Ryuji
    Yamada, Norikazu
    Mitani, Yoshihide
    Ito, Masaaki
    CIRCULATION JOURNAL, 2016, 80 (04) : 989 - +
  • [27] Gb002, A Novel Inhaled Pdgfr Kinase Inhibitor, Demonstrates Efficacy in the Su5416 Hypoxia Rat Model of Pulmonary Arterial Hypertension (pah)
    Galkin, Anna
    Clemons, Bryan
    Garcia, Eduardo
    Brooks, Jennifer
    Slee, Debbie
    Salter-Cid, Luisa
    Zisman, Larry
    CIRCULATION, 2019, 140
  • [28] REDUCTION OF ANTIOXIDANT ACTIVITY IN RATS OF EMPHYSEMA WITH PULMONARY HYPERTENSION INDUCED BY SU5416/HYPOXIA: POTENTIAL ROLES OF VASCULAR ENDOTHELIAL GROWTH FACTOR
    Wada, Yosuke
    Kitaguchi, Yoshiaki
    Yasuo, Masanori
    Hanaoka, Masayuki
    RESPIROLOGY, 2019, 24 : 81 - 81
  • [29] Effect of T-Cell Activity on Susceptibility of Mice for Development of Severe Pulmonary Arterial Hypertension in Response to SU5416 and Chronic Hypoxia
    Taha, Mohamad
    Jiang, Baohua
    Deng, Yupu
    Stewart, Duncan
    CIRCULATION, 2012, 126 (21)
  • [30] The Isoquinoline-Sulfonamide Compound H-1337 Attenuates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Rats
    Shoji, Hiroki
    Yoshida, Yoko
    Sanada, Takayuki Jujo
    Naito, Akira
    Maruyama, Junko
    Zhang, Erquan
    Sumi, Kengo
    Sakao, Seiichiro
    Maruyama, Kazuo
    Hidaka, Hiroyoshi
    Tatsumi, Koichiro
    CELLS, 2022, 11 (01)